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Direct cell-cell interaction of cardiomyocytes is key for bone
marrow stromal cells to go into cardiac lineage in vitro
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Objectives: Cardiac environmental factors are thought to be powerful
inducers in cardiomyogenic differentiation. In this study we simulated the
cardiac environment using coculture and evaluated the cardiomyogenic
differentiation in bone marrow stromal cells.
Methods: In group 1 only bone marrow stromal cells derived from trans-
genic mice expressing green fluorescent protein (GFP-BMCs) were cul-
tured (n  5). In group 2 cardiomyocytes from neonatal rats were grown
on inserts, which we applied to culture dishes seeded with GFP-BMCs
(n  5). In group 3 GFP-BMCs were cocultured with cardiomyocytes on
the same dishes (n  5). We cultured these cells for 7 days and evaluated
the synchronous contraction and the cardiomyogenic differentiation of
GFP-BMCs by means of immunostaining.
Results: In groups 1 and 2 GFP-BMCs protein did not show any myogenic
phenotypes for 7 days. In contrast, in group 3 some GFP-BMCs were incorporated
in parallel with cardiomyocytes and revealed myotube-like formation on day 1. On
day 2, some GFP-BMCs started to contract synchronously with cardiomyocytes.
Myosin heavy chain–positive GFP-BMCs were recognized in 2.49%  0.87% of
the total GFP-BMCs on day 5 (P  .0001). Cardiac-specific troponin I–positive
GFP-BMCs were in 1.86%  0.53% of the total cells on day 5 (P  .0001). Atrial
natriuretic peptide was also seen in GFP-BMCs, and connexin 43 was detected
between GFP-BMCs and cardiomyocytes.
Conclusions: Direct cell-cell interaction with cardiomyocytes was important for
bone marrow stromal cells to differentiate into cardiomyocytes. This coculture was
useful for simulating the cardiac environment in vitro for the research of cell
transplantation in the heart.
Bone marrow cell may be a candidate for cell-based therapy forregenerating many kinds of tissue such as liver, neuron, fat, andtendon,1 and we previously reported that transplantation of bonemarrow stromal cells (BMCs) induced myogenesis and angiogen-esis in damaged hearts and improved impaired function.2,3A part of the transplanted bone marrow cells differentiated into
cardiomyocytes without any artificial manipulation in vivo.2,4-6 Even xenogeneic
stem cells went to site-specific differentiation in the body of another species.7,8
These data suggested that environmental factors were natural inducers of differen-
tiation. The heart might have the capacity to regenerate itself when it is damaged.9
The effects are very difficult to investigate, however, because of their in vivo nature.
We hypothesized that direct attachment between BMCs and cardiomyocytes was
one of the environmental inducers.
In this study we simulated the cardiac environment with coculture composed of
green fluorescent protein mouse-BMCs (GFP-BMCs) and rat cardiomyocytes and
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report, for the first time to our knowledge, that BMCs
differentiate into cardiomyocytes in a coculture and cell-cell
attachment is one of the environmental factors of differen-
tiation.
Materials and Methods
Subjects
Animals were studied on the basis of the “Guide for the Care and
Use of Laboratory Animals” prepared by the Institute of Labora-
Figure 1. Experimental culture system with rat cardiomyocytes (CM) and GFP-BMCs.
Figure 2. The morphology of GFP-BMCs in passage 2 (A and B) and rat cardiomyocytes (CM; C and D) in vitro. A,
These cells were spindle, oval, wedge, or sheet shaped. B, All cells expressed green under fluorescent
microscopy. (Original magnification 200.) D, None of the cells were visible under fluorescent microscopy.
(Original magnification 200.)
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tory Animal Resources, National Research Council, and published
by the National Academy Press, revised 1996, and approved by the
Institutional Animal Care and Use Committee at the National
Cardiovascular Center Research Institute. Pregnant Sprague-Daw-
ley rats were purchased from a licensed vendor. Transgenic mice
expressing green fluorescent protein (C57BL/6Tg14[act-EGF-
P]OsbY01: GFP mouse) were kindly provided by Dr M. Okabe.10
Animals were housed in an air-conditioned room, with free access
to food and water at all times.
BMCs From GFP Mice
A GFP mouse was anesthetized with diethylethanol. After achieve-
ment of general anesthesia, the femora and tibiae were collect-
ed.4,11 After removing connective tissue around the bone, both
ends of the bone were cut. Bone marrow plugs were flushed with
a 27-gauge needle and a syringe filled with complete medium
(Iscove modified Dulbecco medium with 10% fetal bovine serum,
100 U/mL penicillin G, and 100 g/mL streptomycin). Cells were
introduced into 100-mm dishes and incubated at 37°C in 5%
carbon dioxide and 95% air. Three days later, the medium was
changed, and the nonadherent cells were discarded. Medium was
completely replaced every 3 days. Passage was done when con-
fluency exceeded 70%. BMCs in passages 2 or 3 were used in this
study. We operationally called these cells stromal cells.
Neonatal Rat Cardiomyocytes
Cardiomyocytes were isolated from 1-day-old newborn Sprague-
Dawley rats.12 In brief, neonatal rats were anesthetized with di-
ethylethanol and killed by means of decapitation, and their hearts
were rapidly removed and placed into dishes on ice. After the atria
Figure 3. GFP-BMCs with rat cardiomyocytes (CM) on day 2 after coculture in group 3. GFP-BMCs were spindle
shaped, attached to cardiomyocytes, and contracted synchronously with cardiomyocytes. (Original magnification
200.)
Figure 4. The proliferation of GFP-BMCs in groups 1 (solid line) and 3 (dotted line) is shown. There was no
difference between groups 1 and 3 (NS).
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and the great vessels were discarded, hearts were minced into
1-mm3 pieces with fine scissors, transferred to a sterile tube, and
washed once in cold phosphate-buffered saline solution (PBS;
NaCl, 136.9 mmol/L; KCl, 2.7 mmol/L; Na2HPO4, 8.1 mmol/L;
and KH2PO4, 1.5 mmol/L [pH 7.3]) to remove any blood and clots.
The minced tissue was digested in a PBS solution supplemented
with 0.5% trypsin, 0.1% collagenase, and 0.02% glucose for 2
minutes at 37°C. The cell suspension was transferred into a tube
containing 20 mL of complete medium and centrifuged at 1000
rpm for 5 minutes. The cell pellet was resuspended in complete
medium and plated on 35-mm dishes (Falcon; Becton, Dickinson
and Company, Franklin Lakes, NJ) at a density of 1.25  104/cm2
and cultured at 37°C in 5% carbon dioxide and 95% air.
Experimental Culture Systems
GFP-BMCs and cardiomyocytes were prepared as described
above, and 1  105 cells/dish were plated as follows (Figure 1). In
group 1 only GFP-BMCs were plated on 35-mm dishes (Falcon) as
control specimens (n  5). In group 2 cardiomyocytes were plated
onto cell culture inserts (Falcon), which we applied to 35-mm
dishes seeded with GFP-BMCs 2 days later (n  5). In group 3,
cardiomyocytes were plated on 35-mm dishes, followed by addi-
tional plating of GFP-BMCs 2 days later to make up a coculture
(n  5). They were incubated at 37°C in 5% carbon dioxide and
95% air until further processing. All the dishes were then evaluated
for 1 week with a fluorescent microscope (Nikon TE300, Nihon
Kogaku, Tokyo, Japan) equipped with a heated plate (37°C), a
digital video camera, and a confocal microscope (Olympus Fluo-
view, Tokyo, Japan).
Immunohistochemistry
The cultured cells were immunohistochemically stained. In brief,
the cells were washed with PBS and fixed with 4% paraformalde-
hyde for 5 minutes at room temperature, whereas the dishes for
staining against anticonnexin 43 were fixed for 10 minutes at 4°C.
A mouse monoclonal antibody against myosin heavy chain
Figure 5. Myogenic differentiation of GFP-BMCs. Cells were stained with a first antibody against MHC. A was
photographed during the contrast phase. B and C were photographed during the fluorescent phase (B, green,
excitation at 515-540 nm; C, red, excitation at 574-640 nm). D was the double-labeled cell superposition of B and
C. Positive cells showed a cross-striated pattern. Combined green and red fluorescence represented myogenic
cells derived from BMCs. (Original magnification 400.)
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Figure 6. The percentage of MHC–positive BMCs from day 0 through day 5 in group 3. The bar represents mean and
SE. MHC-positive GFP-BMCs appeared from day 1. There was a significant difference among days in group 3 (P <
.0001). As the days passed, the expression of MHC-slow significantly increased to 2.5% on day 5.
Figure 7. ANP-positive BMCs. Cells were stained with a first antibody against ANP. The phases (A-D) were the
same microscopic conditions seen in Figure 5. (Original magnification 400.)
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Figure 8. The percentage of ANP-positive BMCs in group 3. The bar represents mean and SE. Positive cells
appeared on days 2, 3, and 4. Among days, the difference in the percentages were recognized as significant (P 
.039).
Figure 9. Connexin 43–positive BMCs. Cells were stained with a first antibody against connexin 43. Phases A and
B were the same microscopic conditions as in Figure 5. Connexin 43 was detected at the margin of BMCs in phase
C. (Original magnification 600.)
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(MHC)-slow (Sigma, St Louis, Mo) diluted 1:1000 was used to
evaluate the differentiation of striated muscle. A rabbit monoclonal
antibody against atrial natriuretic peptide (ANP; Protos Biotech
Corp, New York, NY) diluted 1:1000 was used to determine the
cardiac-specific expression. Connexin 43 was detected by using a
rabbit polyclonal antibody (Santa Cruz Biotechnology Inc, Santa
Cruz, Calif) diluted 1:1000 and a mouse monoclonal antibody
against cardiac-specific troponin I (TnI; Hytest, 4C2, Euro City,
Finland) diluted 1:200 to detect mature cardiomyocytes. The
dishes were incubated with the first antibodies at 4°C overnight.
The culture dishes were washed with PBS 3 times to remove
unbound antibodies. The primary antibodies anti-MHC-slow and
anti-TnI were detected with a goat anti-mouse IgG antibody (Al-
exa Fluor 568, Molecular Probes, Wako, Osaka, Japan), and anti-
ANP and anti-connexin 43 were detected with a goat anti-rabbit
IgG antibody (Alexa fluor 568, Molecular Probes, Wako, Osaka,
Japan). After incubation, the culture dishes were rinsed with PBS.
The cells were then evaluated and photographed with a Fluoview
FV300 confocal laser scanning microscope equipped with a z-
stepping system (Olympus, Tokyo, Japan).
Quantitative Analysis
The percentage of positively stained cells was determined by using
a fluorescent microscope, and the structure of the differentiated
GFP-BMCs was observed in detail by means of confocal micros-
copy. In briefly, the total cell number was counted in the bright
field. GFP-BMCs were detected with a band beam splitter for
simultaneous excitation at 515 to 540 nm and counted. Alexa dye,
which conjugated the cells, was visualized with a band beam
splitter for simultaneous excitation at 574 to 640 nm. The percent-
age of positively stained cells was calculated in 4 randomly se-
lected fields of 5 culture dishes from the initial plating (day 0)
through the seventh day (day 7).
Statistical Analysis
Statistical analysis was performed with StatView 5.0 software
(SAS Institute, Inc, Cary, NC). All values are expressed as
means  SE. Comparison of the growth rate between 2 distinct
groups was analyzed by using the Mann-Whitney U test. Compar-
ison of the data among days in each group was performed with the
Kruskal-Wallis test.
Figure 10. TnI–positive BMCs. Cells were stained with a first antibody against TnI. The phases (A-D) were the same
microscopic conditions as in Figure 5. Some BMCs stained positively and showed myofibrils lengthwise along the
cell. The expression of TnI corresponded to green fluorescence derived from BMCs. (Original magnification 400.)
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Results
Morphologic Changes of GFP-BMCs and
Cardiomyocytes
Although GFP-BMCs were cultured and passaged, nonad-
herent cells were eliminated, and spindle-shaped cells
formed colonies and proliferated rapidly. All of the GFP-
BMCs but red blood cells expressed bright green fluores-
cence (Figure 2). Contracting cardiomyocytes were identi-
fied on day 1. Contracting frequency per minute of beating
cardiomyocytes was 60 to 70. On day 2, a few neonatal
cardiomyocytes connected each other, and the beating rate
was 70 to 80 per minute. None of the cardiomyocytes was
visible under the fluorescent condition (Figure 2). In group
1 the shapes of these cells varied (ie, spindle, oval, wedge,
or sheet), and they did not show any contraction. In group 2
GFP-BMCs did not contract. The shape and proliferation of
GFP-BMCs were not different from those in group 1. In
group 3, however, on day 1, part of the spindle-shaped
GFP-BMCs attached in parallel to the colony of contracting
cardiomyocytes (12.5%  1.8%), whereas flattened GFP-
BMCs covered the cardiomyocyte layer at random. On day
2, we found that GFP-BMCs attached to nonfluorescent
contracting cells (cardiomyocytes) started to contract syn-
chronously with cardiomyocytes (5.6%  2.3%, Figure 3).
The beating rate was almost 60 to 80 per minute. On day 5,
GFP-BMCs began forming colonies and maintained syn-
chronous contraction (15.6%  4.2%). As time passed, the
contracting cells communicated, and almost all the fields
contracted synchronously. The proliferation of the GFP-
BMCs between groups 1 and 3 was not different in this
study (Figure 4). After day 6, the cultured cells were peeled
off, and we could not evaluate them immunocytologically.
Phenotypic Changes of GFP-BMCs
In groups 1 and 2 GFP-BMCs did not express any type of
myogenic or gap junction proteins. In contrast, in group 3
GFP-BMCs started to express MHC at 0.14%  0.09% of
the total GFP-BMCs on day 1. The MHC-positive BMCs
increased day by day and were recognized at 2.49% 
0.87% on day 5 (Figures 5 and 6). The double-labeled cells
indicated that striated muscles originated from GFP-BMCs,
and almost all of these cells had dinuclei. The ANP-positive
BMCs were detected mainly on days 2 and 3 (0.78% 
0.56%, Figures 7 and 8). As the days passed, the ANP-
positive BMCs decreased on day 4 and disappeared on day
5. Connexin 43 was identified between GFP-BMCs and
unlabeled cardiomyocytes from day 2 through day 5 (Figure
9). The cardiac-specific TnI-positive BMCs appeared at
1.11%  0.42% on day 4 and increased to 1.86%  0.53%
on day 5 (Figures 10 and 11). The results are summarized in
Table 1. Groups 1 and 2 did not show any myogenic
differentiation of GFP-BMCs. In contrast, GFP-BMCs in
group 3 expressed MHC first, followed by the expression of
connexin 43 and ANP. Finally, GFP-BMCs expressed TnI.
Some GFP-BMCs stained positive against myogenic pro-
teins attached directly to cardiomyocytes and some attached
to cardiomyocytes through nonmyogenic cells.
Discussion
The evidence of cardiomyogenic differentiation of bone
marrow cells in vivo suggests the existence of environmen-
tal factors.2,4-6 However, these factors are not well known
because they are in vivo phenomena, making investigation
difficult. Possible factors might include cell-cell interaction,
Figure 11. The percentage of cardiac-specific TnI–positive BMCs in group 3. The bar represents mean and SE.
Positive cells appeared on day 4 and increased to 1.9% on day 5. The differences of the positive BMCs were
recognized to be significant among days (P < .0001).
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electrical and mechanical stimulation, and unknown growth
factors.
We hypothesized the cell-cell interaction was a cardio-
genic inducer for stem cells and set up a coculture to
simulate the in vivo phenomena by using GFP-BMCs and
cardiomyocytes, which have 2 advantages. First, GFP-
BMCs are visible because the cells are alive. Contraction is
a typical characteristic of myogenic cells, which is only seen
in living cells. We can see the interaction between GFP-
positive cells and GFP-negative cells dynamically. Second,
GFP-BMCs facilitated 100% labeling efficiency, which en-
abled us to differentiate GFP-BMCs from cardiomyocytes.
In other words it was possible to perform quantitative anal-
ysis of GFP-BMCs without false-negative and false-positive
contamination. The cultured GFP-BMCs maintained green
fluorescence strongly for at least 8 weeks. GFP-BMCs pro-
liferated as C57 mouse-derived BMCs.
This study also has a characteristic: the simulation of
xenogeneic cell transplantation from mice to rats in vitro.
Even if xenogeneic cell transplantation has several issues, it
might provide commercial availability in the future if im-
munologic problems are solved.7
Reinecke and colleagues13 reported that some skeletal
myoblasts contracted synchronously with adjacent cardio-
myocytes in vitro. However, skeletal myoblasts did not
differentiate into cardiomyocytes. Makino and associates14
and ourselves2 reported that BMCs were induced into car-
diomyogenic cells with chemicals. In contrast, in this study
we did not use any chemicals and only cocultured with
cardiomyocytes. We showed here that multinuclei GFP-
BMCs differentiated into cardiomyogenic cells. GFP-BMCs
started to contract synchronously with cardiomyocytes. Iso-
proterenol (25 nmol/L) increased the heart rate of the GFP-
BMCs and the cardiomyocytes from 80 to 100 per minute
(unpublished data). This mechanism could also happen in
vivo.4,7
There are some possible reasons why groups 1 and 2 did
not show the cardiac differentiation of GFP-BMCs. Al-
though BMCs have the capacity for cardiac differentiation,
they might need some triggers, such as 5-azacytidine.2,14
Furthermore, unknown soluble inducers might not exist or
might exist only at low concentrations. We regarded the
direct attachment with cardiomyocytes as one of the impor-
tant triggers for the cardiogenic differentiation of GFP-
BMCs.
Our results indicated that GFP-BMCs cocultured with
cardiomyocytes expressed myogenic protein as the first
step, gap junction protein and ANP as the second step, and
TnI as the final step. In contrast to increasing MHC and TnI
values, ANP vanished on day 5. ANP is important for
proliferation in embryonal cardiac development.15 Cardio-
myogenic (CMG) cells from bone marrow stroma also
expressed ANP.16 The myogenic cells might have lost ANP
as a result of ventricular phenotypic change.
Although we observed the differentiation of GFP-BMCs,
the percentage of differentiated cells was low. We consid-
ered the possible reasons. We did not purify specific cell
types, such as CD34, in this study. Therefore, cultured cells
were heterogeneously populated, and only a very small
percentage of the BMCs were pluripotent stem cells,
whereas most others were lineage-destined progenitor cells.
In this study we evaluated this coculture for only 1 week
because the cultured cells were detached from the bottom of
dishes as a result of overconfluency. Given the time-depen-
dent increase of MHC- and TnI-positive cells, the percent-
age of cardiomyogenic cells from GFP-BMCs might in-
crease if a longer culture is possible. We simulated BMC
transplantation into the normal myocardium in this study.
Stem cells are thought to be subtle in the normal tissue. On
the other hand, injury, including ischemia, might trigger
these cells to be active.
Cell fusion was suggested as an explanation for stem cell
plasticity.17,18 In contrast, another group19 was against the
fusion theory because single euploid multipotent adult pro-
genitor cells differentiated into cells of 3 germ layers in
vitro. They showed a high frequency of chimerism in com-
parison with the results of the previous study.17 Some in
vivo studies have reported a robust (30%-50%) level of
transdifferentiation.20 Although we cannot exclude the pos-
sibility of cell fusion, our conversion rate (2.5%) was much
higher than the frequency of spontaneous fusion (2-11
clones out of 106 BMCs; 0.0002%-0.0011%).17 The mech-
Table 1. The trend of time-dependent expression of pro-
teins
MHC: Myosin heavy chain slow. ANP: Atrial natriuretic peptide. TnI:
Troponin I. : some cells expressed protein. : negative.
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anism of differentiation of stem cells should be investigated
more deeply in future studies.
We used neonatal cardiomyocytes because we wanted to
see contractions not seen in adult cardiomyocytes in vitro.
The combination of adult cardiomyocytes and GFP-BMCs
might be evaluated later.
The present study provides the first demonstration, to our
knowledge, of the cardiomyogenic differentiation of BMCs
without any chemicals in vitro. Using this coculture, we
might be able to identify specific substances regulating
cardiac development in the future.
We thank Ms K. Hattori for her help in breeding the GFP mice.
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Discussion
Dr Frank W. Sellke (Boston, Mass). How do you know that it
is due to direct cell-to-cell contact or interaction and that there is
not some substance secreted that causes this effect?
Dr Tomita. Of course, from only the observation under the
microscope, we do not know about that in detail. Some unknown
soluble factors might go through gap junctions, and we speculated
another mechanism of induction. We saw some TnI–positive cells
derived from GFP-BMCs attached to GFP-negative cells, which
were TnI negative. This observation suggested that some BMCs
differentiated to cardiomyocytes by means of mechanical stretch-
ing. Therefore, there are several inducers in this system.
Dr Henry M. Spotnitz (New York, NY). What do you think the
mediators are of this effect that are passing through the gap
junctions?
Dr Tomita. Thus far I have no concrete evidence.
Dr Spotnitz. You are sure that these cells are being trans-
formed and that they are not really myocytes?
Dr Tomita. Do you mean that the phenomenon is due to
fusion?
Dr Spotnitz. Yes.
Dr Tomita. There were landmark articles regarding fusion
between embryonic stem cells and BMCs published in the journal
Nature in April. They include a warning that reported differenti-
ation might be due to fusion.But in this study we just cultured
cardiomyocytes and BMCs and not embryonic stem cells. Of
course there are some possibilities, but embryonic stem cells are
very energetic and immature. They are easy to communicate, and
in the in vivo situation we put BMCs in the adult heart. They are
not embryonic stem cells. Therefore, it is a different story.
Dr Marcio Scorsin (Curitiba, Brazil). I have some doubts
concerning the fate of transplanted BMCs into a myocardial in-
farction scar. It is widely accepted that those cells might have a
milieu-dependent differentiation (becoming cardiomyocytes) in
normal myocardium. However, if you inject those cells into a
myocardial scar, according to some studies, they would produce
angiogenesis and differentiate into fibroblasts instead of cardio-
myocytes. My question is whether you think that it is important to
differentiate BMCs before transplantation.
Dr Tomita. For the in vivo study, it is not necessary to convert
all BMCs into cardiomyocytes. For example, if you put BMCs into
the scar, they might go in like myofibroblasts, but the myofibro-
blasts are also important to prevent extension of the scar. I saw
some TnI–positive cells from transplanted BMCs in the scar tissue
in the previous study. I agree to the hypothesis that fibroblasts are
strong inducers for BMCs to transform to fibroblasts.
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